Psilocybin

Healthcare Workers Back Psychedelics But Lack Crucial Knowledge, Study Finds

Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids

Patents Reveal New Prodrugs For Psilocin, Promising Reliable Mental Health Treatments

Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids

Patents Reveal New Prodrugs For Psilocin, Promising Reliable Mental Health Treatments

Relaxation Emerges As Strongest Predictor Of Psychedelic Therapy Benefits, Study

Psychedelic Mushrooms Market Poised For $3.3 Billion Surge By 2031

Relaxation Emerges As Strongest Predictor Of Psychedelic Therapy Benefits, Study

Psychedelic Mushrooms Market Poised For $3.3 Billion Surge By 2031

UK Breaks New Ground With First Government-Backed Psilocybin Therapy For Opioid Crisis

Pro Golfers Turn To Psychedelics For Focus Boost And Anxiety Relief

Psilocybin Recent News

Elon Musk And Joe Rogan Criticize Psychedelics And Big Pharma's Legacy Of Profit Over Public Health

Joe Rogan and Elon Musk discuss the pharma industry's history of prioritizing profits over health, sparking debate on drug safety and ethics.

Americans Favor Psilocybin For Mental Health Treatment, Study Finds

Most Americans support psilocybin use for mental health and well-being, a new study shows, marking a shift in attitudes toward psychedelics.

Psychoanalysis Meets LSD: Argentina's Lost 1950s Era Of Psychedelic Therapy

Explore Argentina's golden era of psychedelic therapy (1957-1967), where LSD and psychoanalysis merged for mental health treatments.

Online Mushroom Market Booms: Experts Say Be Very Careful

Websites selling psilocybin are popping up, betting on legalization. But safety and legal concerns persist as the unregulated market grows.

Magic Mushroom Strains: Is There Really A Difference?

New research suggests magic mushroom strains are more alike than different. Focus on cultivation techniques, not strain names, to enhance potency and effects.

Massachusetts Veterans Advocate For Psilocybin Legalization: Will Voters Support Them?

The Optimism Experiment: Psilocybin's Impact On Motivation

Researchers found psilocybin increased optimism in rats, suggesting potential benefits for treating depression symptoms in humans.

Could Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says Yes

Over 5 million Americans with depression could be eligible for psilocybin-assisted therapy if FDA-approved, signaling vast market potential.

Missouri Allocates $5M For Psilocybin Research To Treat Opioid Addiction

Missouri dedicates $5M from its opioid settlement fund to psilocybin research for treating opioid addiction, seeking expert input on this project.

Michigan Bill Could Legalize Psychedelic Mushrooms For PTSD Treatment

Michigan introduces a bill to legalize psychedelic mushrooms for PTSD treatment, allowing adults to possess up to two ounces for personal use

Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder

New study suggests psilocybin may help treat body dysmorphic disorder by rewiring brain connectivity and reducing obsessive thought patterns.

Minnesota Moves Forward With Psilocybin Therapy Plan, Eyes Broader Psychedelic Reforms

Minnesota's Psychedelic Task Force advances a clinical psilocybin therapy program, with broader decriminalization still under consideration.

DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling

The DEA increases production quotas for psychedelics like psilocybin and ibogaine, while marijuana quotas remain stable ahead of a possible rescheduling decision.

Psilocybin Found To Be As Effective As Lexapro In Treating Depression, Researchers Say

Psilocybin rivals antidepressants in treating depression while offering long-term well-being benefits, according to a new study.

Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition

Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder, bolstering its clinical pipeline with key acquisitions and partnerships.

Magic Mushrooms Boosted Humanity's Evolutionary Success, New Study Says: Did Psilocybin Make Early Humans Better Hunters?

New research suggests psilocybin mushrooms may have shaped human consciousness, supporting the Stoned Ape Hypothesis and sparking evolutionary leaps

Psyence Biomed Launches First Trial Site In Australia For Phase IIb Psilocybin Study In Palliative Care

Psyence Biomed initiates a Phase IIb psilocybin trial in Australia to explore its potential as a treatment for Adjustment Disorder.

Psilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive Effects

Psilera's trip-free psilocybin drug PSIL-006 clears key safety milestone, potentially offering a breakthrough treatment for frontotemporal dementia.

Athletes Embrace Psychedelic Therapy For Concussion Symptoms, More Than One-Third Say It Helps

Single-Dose Psilocybin Therapy Shows Promise For Treating Alcohol Use Disorder, Study Finds

New study shows single-dose psilocybin therapy may reduce alcohol consumption in alcohol use disorder patients, offering a promising new treatment approach.

Mike Tyson Sparks Psychedelic Buzz: Athletes Embrace Magic Mushrooms To Increase Focus And Recovery

Mike Tyson sparks a trend as more athletes turn to magic mushrooms, raising questions about the role of psychedelics in sports.

Fed Health Agency Funds $2.4M Study On Psychedelics Treatment For Meth Addiction

NIH awards $2.4M to study psychedelics as a potential treatment for methamphetamine addiction, aiming to uncover new therapeutic approaches.

Psychedelics Enhance Creativity After Use, But MDMA Disrupts Memory, Study Shows

New research reveals distinct cognitive effects of psychedelics and MDMA, showing that psychedelics may impair focus but boost creativity, while MDMA primarily disrupts memory.